|
| | valid until |
| Stand 22.11.2024 | | | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | Dec |
|---|
| Group | Material | RVNR | 2025 | 2025 | 2025 | 2025 | 2025 | 2025 | 2025 | 2025 | 2025 | 2025 | 2025 | 2024 |
|---|
| Haemostasis I (TPZ,INR,aPTT) | Plasma | 221 | | | | | | | | | | | 1734 | |
| Haemostasis II (Fib,TT) | Plasma | 222 | | | | 1760 | | | 1710 | | | | 1673 | |
| Haemostasis III (FII, FV, FVII, FX) | Plasma | 223 | | | | 1761 | | | 1712 | | | | 1678 | |
| Haemostasis IV (Factor IX,XI,XII,XIII) | Plasma | 224 | | | | 1762 | | | | | | | 1674 | |
| Haemostasis V (AT, Prot-C, Prot-S) | Plasma | 225 | | | | 1763 | | | 1711 | | | | | |
| Haemostasis VI (D-Dimer) | Plasma | 226 | | | | 1764 | | | | | | | 1675 | |
| Haemostasis VII ( Faktor VIII chromogen) | Citrat-Plasma | 227 | | | | 1765 | | | | | | | | |
| Haemostasis VII (vWF-AG, vWF-RiCof, FVIII) | Plasma | 227 | | | | | | | | | | | 1677 | |
| Haemostasis XXIII (Rivaroxaban) | Plasma | 503 | | | | | | | 1717 | | | | | |
| Haemostasis XXV (Apixaban) | Plasma | 504 | | | | | | | 1718 | | | | | |
| Haemostasis XXXII (Edoxaban) | Plasma | 505 | | | | | | | 1719 | | | | | |
| Haemostasis XXXIII (Emicizumab) | Plasma | 506 | | | | 1766 | | | 1720 | | | | | |
| Haemostasis-ECAT (APC/antiXa/FVIII-Inh/FIX-Inh/PAI-1) | Plasma | TH | | | | | | | 0378. | | 0362, | | | |
| Haemostasis-ECAT (Lupus) | Plasma | TH | | | | | | | 0377; | | 0363, | | | |
| Haemostasis-ECAT (Plasminogen,Antiplasmin) | Plasma | TH | | | | | | | 0379. | | | | | |
| Haemostasis-ECAT (Thrombin Generation Test) | Plasma | TG | | | | | | | | | 0364, | | | |
| Hematology Auto Differentials (CAP) | EDTA | FH9 | | | | | | | | 0433- | | | 0423- | |
| Hemoglobin A1c (CAP) | EDTA | GH2 | | | | | | | | 0432 | | | | 0420 |
| Hormones (RFB) | Serum | HP | | | | | | | | 0385, | | | 0376. | |
| Hormones-Fertility | Serum | 297 | | | | 1743-1 | | | | | 1684-1 | 1743 | | |
|